Purchases and Sales Made in Q1 2024 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q1 2024. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Monashee Investment Management LLC
Boston, MA |
SELL
|
- |
-12.7K- 12.68% |
$448K - $659K
|
87.5K
$1.97M
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-13.1K- 87.51% |
$462K - $680K
|
1.87K
$42K
|
|
|
May 10, 2024
Q1 2024
|
Creative Planning
Overland Park, KS |
SELL
|
- |
-18.3K- 78.69% |
$643K - $947K
|
4.94K
$111K
|
|
|
May 15, 2024
Q1 2024
|
Twinbeech Capital LP
Purchase, NY |
SELL
|
- |
-18.6K- 50.11% |
$656K - $967K
|
18.5K
$417K
|
|
|
May 09, 2024
Q1 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-20.4K- 71.41% |
$718K - $1.06M
|
8.16K
$183K
|
|
|
May 06, 2024
Q1 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-25.8K- 56.0% |
$909K - $1.34M
|
20.3K
$456K
|
|
|
May 15, 2024
Q1 2024
|
Kennedy Capital Management, Inc.
St Louis, MO |
SELL
|
- |
-28.6K- 45.98% |
$1.01M - $1.48M
|
33.6K
$755K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-28.7K- 38.05% |
$1.01M - $1.49M
|
46.8K
$1.05M
|
|
|
May 15, 2024
Q1 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-38.6K- 12.24% |
$1.36M - $2.01M
|
277K
$6.22M
|
|
|
May 15, 2024
Q1 2024
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-40.2K- 36.12% |
$1.42M - $2.09M
|
71.1K
$1.6M
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-40.9K- 32.36% |
$1.44M - $2.12M
|
85.4K
$1.92M
|
|
|
May 15, 2024
Q1 2024
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-42.2K- 5.0% |
$1.49M - $2.19M
|
802K
$18M
|
|
|
May 15, 2024
Q1 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-43K- 5.7% |
$1.51M - $2.23M
|
711K
$16M
|
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-43.2K- 16.78% |
$1.52M - $2.24M
|
214K
$4.82M
|
|
|
May 15, 2024
Q1 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-76.4K- 2.44% |
$2.69M - $3.96M
|
3.06M
$68.7M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-79.2K- 54.27% |
$2.79M - $4.11M
|
66.7K
$1.5M
|
|
|
May 15, 2024
Q1 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-97.3K- 9.8% |
$3.43M - $5.05M
|
896K
$20.1M
|
|
|
May 15, 2024
Q1 2024
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-106K- 3.52% |
$3.73M - $5.49M
|
2.9M
$65.2M
|
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-168K- 99.39% |
$5.93M - $8.73M
|
1.04K
$23.3K
|
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-187K- 81.16% |
$6.59M - $9.7M
|
43.4K
$976K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-282K- 42.87% |
$9.94M - $14.6M
|
376K
$8.45M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-282K- 42.87% |
$9.94M - $14.6M
|
376K
$8.45M
|
|
|
May 15, 2024
Q1 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-381K- 29.79% |
$13.4M - $19.8M
|
899K
$20.2M
|
|
|
May 15, 2024
Q1 2024
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-511K- 14.08% |
$18M - $26.5M
|
3.12M
$70.1M
|
|
|
May 14, 2024
Q1 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-730K- 32.82% |
$25.7M - $37.9M
|
1.49M
$33.6M
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.47M- 53.42% |
$51.9M - $76.4M
|
1.28M
$28.8M
|